<DOC>
	<DOCNO>NCT01794364</DOCNO>
	<brief_summary>The primary purpose trial evaluate safety tolerability , pharmacokinetics , pharmacodynamics single oral dos PF-06291874 healthy volunteer .</brief_summary>
	<brief_title>Single Dose Safety , Tolerability , Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject non childbearing potential . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include clinically significant drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>T2DM</keyword>
	<keyword>Diabetes Mellitus Type 2</keyword>
</DOC>